Ranheim, Norway

Trond Erling Ellingsen

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 32(Granted Patents)


Location History:

  • Trondheim, NO (2013 - 2018)
  • Ranheim, NO (2006 - 2019)

Company Filing History:


Years Active: 2006-2019

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Trond Erling Ellingsen: Innovator in Antimicrobial Compounds

Introduction

Trond Erling Ellingsen is a notable inventor based in Ranheim, Norway. He holds a total of nine patents, showcasing his contributions to the field of antimicrobial agents and genetic engineering. His work has significant implications for pharmaceutical applications and biotechnology.

Latest Patents

Ellingsen's latest patents include an innovative antimicrobial compound. This invention provides a new compound, a method to produce it, and its use as an antimicrobial agent. It also includes pharmaceutical compositions that comprise this compound. Additionally, he has developed a patent related to the NRPS-PKS gene cluster and its manipulation and utility. This nucleic acid molecule comprises a nucleotide sequence that is essential for the synthesis of polyketide-based or macrolactam molecules. The nucleic acid molecule may be used to prepare a modified BE-14106 biosynthetic gene cluster for the preparation of a modified BE-14106 molecule.

Career Highlights

Throughout his career, Ellingsen has worked with prominent companies such as Sinvent AS and Sintef TTO AS. His experience in these organizations has contributed to his expertise in the development of innovative solutions in biotechnology.

Collaborations

Ellingsen has collaborated with notable professionals in his field, including Sergey Zotchev and Trygve Brautaset. These collaborations have further enhanced his research and development efforts.

Conclusion

Trond Erling Ellingsen is a distinguished inventor whose work in antimicrobial compounds and genetic engineering has made a significant impact in the field. His innovative patents and collaborations reflect his commitment to advancing biotechnology and pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…